Trial Profile
Evaluation of rosiglitazone in reversing metabolic defects of pre-diabetes and type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Apr 2008 Status change
- 19 Apr 2008 New trial record.